51 F
New York
Tuesday, April 20, 2021

RedHill [NASDAQ: RDHL] Announces Partnership With Cosmo Pharma

Must read

IAA [NYSE: IAA] Announces Expansion of Delivery Services in the UK

IAA, Inc. disclosed that its UK-based business unit has decided to expand its vehicle delivery services for its buyers. This expansion decision has...

ICON [NASDAQ: ICLR] Secures Multiple Categories in 2021 CRO Leadership Awards

ICON Public Limited Company has disclosed that it has won multiple categories in the annual CRO Leadership Awards. This is another greatest achievement...

Equinox Announces Sale of Pilar Gold Mine

Equinox Gold Corp. revealed Monday that it has decided to sell its Pilar Gold Mine in Brazil to Pilar Gold Inc. The firm...

OpGen [NASDAQ: OPGN] Announces Strategic Collaboration New York State Department of Health

OpGen, Inc. revealed that it has entered into a strategic collaboration deal with the New York State Department of Health. The focus of...

RedHill Biopharma Ltd. [NASDAQ: RDHL] disclosed Thursday it has partnered with Cosmo Pharmaceuticals. Both the companies entered into an agreement for exclusive licensing for multiple products.

After the agreement, RedHill & Cosmo will join hands to co-develop a novel next-generation therapy for the removal of H. pylori infection.

Shares of RedHill soared 2.45%, or up +0.22 during the trading of Wednesday. It had opened at $9.07 and has a previous close of $9.19. It has a day low and high range of $8.67-$9.37, respectively.

In the past 52-weeks of trading, its stocks have fluctuated between the low of $3.26 and a high of $10.17. RedHill has moved up 181.72% from its 52-weeks low and decreased -9.64% from its 52-weeks high.

If we look at the profitability of RedHill, its return on assets (ROA) is -64.50%. Its return on equity (ROE) is -125.20%, and return on investment (ROI) is-67.70%. Additionally, its Gross Margin is 36.60%.

Cosmo is to get Exclusive European right and planned to give $7 million to RedHill upon signing of the licensing agreement. Cosmo will pay an extra $2 million after receiving approval in Europe. The company also decided to pay 30% royalties.

Furthermore, RedHill and Cosmo decide to jointly conduct formally approved clinical trials in the US and Europe at the same time, at a cost split of 70% RedHill and 30% Cosmo.

Cosmo will become the manufacturer for the next-generation therapy for the removal of H. pylori infection, Movantik, and RHB-204 for pulmonary nontuberculous mycobacteria (NTM) infections.

More articles

Latest article

Why Mer Telemanagement [NASDAQ: MTSL] Skyrocketed on Friday?

Shares of Mer Telemanagement Solutions Ltd skyrocketed during the trading session of Friday. The strong performance of the firm has indicated the positive...

Largo Resources Gets Approval for Listing on Nasdaq Stock Exchange

Largo Resources disclosed that it has finally obtained authorization from Nasdaq Stock Market LLC. As per the approval, the firm will now eligible to...

Aurora Mobile [NASDAQ: JG] Inks Agreement with Wanda Film

Aurora Mobile Limited disclosed Thursday that it has inked an agreement with Wanda Film Holding Co Ltd. Since its inception, Aurora Mobile has...

Brady [NYSE: BRC] Commence Tender Offer to Buy Nordic ID Oyj

Brady Corporation has inked an agreement with Nordic ID for its acquisition. The firm has commenced the tender offering to buy all the...

Cinedigm [NASDAQ: CIDM] Achieve Record Subscription and Ad-Supported User Growth Milestones

Shares of Cinedigm Corp. skyrocketed 19.30% after the firm reported the update about the subscription. The firm has achieved the best ever achievement...

Aurora Mobile [NASDAQ: JG] Signs Partnership Agreement with Yivi

Aurora Mobile Limited revealed that it has inked a collaboration deal with Hangzhou Yivi Intelligent Technology Co., LTD. (Yivi). Yivi and Aurora both...

Total [NYSE: TOT] Join Forces with Siemens Energy to Reduce LNG Related Emissions

Total SE has joined forces with Siemens Energy to explore the solution for the reduction of CO2 emissions. The firms have inked a...

Kaixin [NASDAQ: KXIN] Signs Cooperation Agreement with Jingdong

Kaixin Auto Holdings declared Monday that it has inked a deal with Jingdong Century Trade Limited. The agreement is the collaboration agreement between...